FINWIRES · TerminalLIVE
FINWIRES

Kehua Bio-Engineering Gets Registration Certificate for Nucleic Acid Kit

By

Shanghai Kehua Bio-Engineering (SHE:002022) received a medical device registration certificate from China's National Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.

The certificate, which is valid until May 10, 2031, is for the fully automated nucleic acid purification and amplification detection system.

The Chinese in vitro diagnostics company's shares slipped 1% at the close.

Related Articles